Johnson & Johnson (JNJ)
155.00
-0.50
(-0.32%)
USD |
NYSE |
Nov 22, 12:58
Johnson & Johnson Free Cash Flow: 19.02B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 19.02B |
| June 30, 2024 | 19.83B |
| March 31, 2024 | 18.23B |
| December 31, 2023 | 17.78B |
| September 30, 2023 | 15.74B |
| June 30, 2023 | 14.55B |
| March 31, 2023 | 16.21B |
| December 31, 2022 | 17.18B |
| September 30, 2022 | 17.74B |
| June 30, 2022 | 19.95B |
| March 31, 2022 | 19.73B |
| December 31, 2021 | 19.76B |
| September 30, 2021 | 22.46B |
| June 30, 2021 | 22.56B |
| March 31, 2021 | 20.85B |
| December 31, 2020 | 20.19B |
| September 30, 2020 | 18.31B |
| June 30, 2020 | 17.44B |
| March 31, 2020 | 19.76B |
| December 31, 2019 | 19.92B |
| September 30, 2019 | 19.71B |
| June 30, 2019 | 18.38B |
| March 31, 2019 | 18.47B |
| December 31, 2018 | 18.53B |
| September 30, 2018 | 18.47B |
| Date | Value |
|---|---|
| June 30, 2018 | 18.49B |
| March 31, 2018 | 18.37B |
| December 31, 2017 | 17.78B |
| September 30, 2017 | 18.47B |
| June 30, 2017 | 17.62B |
| March 31, 2017 | 16.34B |
| December 31, 2016 | 15.54B |
| September 30, 2016 | 13.70B |
| June 30, 2016 | 14.43B |
| March 31, 2016 | 15.33B |
| December 31, 2015 | 16.11B |
| September 30, 2015 | 15.50B |
| June 30, 2015 | 14.05B |
| March 31, 2015 | 14.03B |
| December 31, 2014 | 15.00B |
| September 30, 2014 | 14.60B |
| June 30, 2014 | 15.83B |
| March 31, 2014 | 15.42B |
| December 31, 2013 | 13.82B |
| September 30, 2013 | 13.33B |
| June 30, 2013 | 12.49B |
| March 31, 2013 | 11.86B |
| December 31, 2012 | 12.46B |
| September 30, 2012 | 12.56B |
| June 30, 2012 | 12.17B |
Free Cash Flow Range, Past 5 Years
14.55B
Minimum
Jun 2023
22.56B
Maximum
Jun 2021
18.86B
Average
19.38B
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
| AbbVie Inc | 15.62B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.993B |
| Cash from Investing (Quarterly) | -3.128B |
| Cash from Financing (Quarterly) | -9.882B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 11.45B |
| Free Cash Flow to Firm (Quarterly) | 5.714B |
| Free Cash Flow Yield | 5.06% |